Sugi Predict

Sugi Predict / Targets / RNF213

RNF213

E3 ubiquitin-protein ligase RNF213 · Q63HN8 · RNF213 on Sugi Atlas →

0 patent compounds predicted against RNF213, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RNF213 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome PHASE1/PHASE2ACTIVE_NOT_RECRUITING
Olaparib in Patients With HRD Malignant Mesothelioma PHASE2RECRUITING
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS) PHASE1COMPLETED
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome nanCOMPLETED
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
RORC Genetic Polymorphism of Rheumatoid Arthritis nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome nanRECRUITING
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 nanUNKNOWN
Panomics Relationships in the Epidemiology of Cancer Through In Silico Expression (PRECISE) nanWITHDRAWN
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 nanRECRUITING
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Diagnosis of Prader-Willi Syndrome and Angelman Syndrome nanCOMPLETED
Identification of Genes Predisposing to Atherosclerosis nanCOMPLETED
Genetic Studies of Inflammatory Bowel Disease nanCOMPLETED
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
A Positional Cloning Study on Schizophrenia nanCOMPLETED
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer nanCOMPLETED
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes nanRECRUITING
Molecular Genetic Study of Schizophrenia: Parent-Offspring Trios nanCOMPLETED
Establishment of a Prospective Clinical-biological Database nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RNF213 binder may also engage these)

ProteinNameSimilarity
E9Q555 — 1.000 E9Q555 →
O35870 — 0.997 O35870 →
Q8BV79 — 0.996 Q8BV79 →
P11299 — 0.996 P11299 →
Q9UJT2 — 0.996 Q9UJT2 →
Q9Z2U2 — 0.994 Q9Z2U2 →
A0JMD2 — 0.994 A0JMD2 →
A0A0R4IBK5 — 0.994 A0A0R4IBK5 →
Q7L3B6 — 0.994 Q7L3B6 →
Q75QN2 — 0.993 Q75QN2 →
Q07851 — 0.993 Q07851 →
Q8CCG4 — 0.993 Q8CCG4 →
Q6NRW0 — 0.993 Q6NRW0 →
Q80UW3 — 0.993 Q80UW3 →
Q5DW34 — 0.992 Q5DW34 →
Q3UIZ8 — 0.992 Q3UIZ8 →
Q90WN7 — 0.992 Q90WN7 →
EHMT1 Histone-lysine N-methyltransferase EHMT1 0.992 landscape →
Q8TDB6 — 0.992 Q8TDB6 →
Q6GQV0 — 0.992 Q6GQV0 →
Q8K389 — 0.992 Q8K389 →
A5WV69 — 0.992 A5WV69 →
Q5XIX0 — 0.992 Q5XIX0 →
O43310 — 0.992 O43310 →
E1C7U0 — 0.992 E1C7U0 →
Q99698 — 0.992 Q99698 →
O15050 — 0.992 O15050 →
Q4KLZ4 — 0.991 Q4KLZ4 →
Q9NYI0 — 0.991 Q9NYI0 →
Q2T9I9 — 0.991 Q2T9I9 →